11:27 AM EST - Microbix Biosystems Inc. : Reports results for its second quarter and first half of fiscal 2025 ended March 31, 2025. Results for H1 were largely satisfactory, with recurring revenues increasing by 14% to $11.4 million, gross margin on those sales increasing by 10% to 61%, and net income of $0.9 million. Microbix Biosystems Inc.
shares T.MBX are trading down $0.02 at $0.34.
